Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. cryo2

CryO2

Telemetric control of oxygen delivery for therapy optimization and adherence

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 CryO2 project word cloud

Explore the words cloud of the CryO2 project. It provides you a very rough idea of what is the project "CryO2" about.

600    wireless    poor    solutions    pneumologists    envisage    tanks    4    transform    integration    valuable    intensively    central    prevention    strengthen    rising    reducing    72    receive    home    telephone    follow    service    sign    adherence    algorithm    revenue    services    exacerbation    4million    version    consumption    vital    readily    base    ltot    39    2023    tested    business    o2    remote    therapy    position    billion    closely    industry    units    telemedicine    annually    launch    13    personal    usa    18k    device    sensor    integral    global    monitoring    care    potentiating    q4    patients    full    hospitalization    source    wsn4life    cryo2    regulation    providers    facet    oxygen    trl    signs    2018    remotely    visits    intend    prototype    provision    sensors    20    roi    grade    basis    flux    flow    30    thinsp    upgraded    innovative    opportunity    distress    automatic    health    disease    evolution    sold    telemetric    solution    worldwide    patient    miniaturization    million    30k    estimate    commercial    medical    finalizing   

Project "CryO2" data sheet

The following table provides information about the project.

Coordinator		 WIRELESS SENSOR NETWORKS SRL 

Organization address
address: VIA L. MANARA 31
city: MONZA
postcode: 20900
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Italy [IT]
 Project website http://www.wsn4life.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2017-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    WIRELESS SENSOR NETWORKS SRL IT (MONZA) coordinator 50˙000.00

Map

 Project objective

'One million patients receive long-term oxygen therapy (LTOT) in the USA and 600,000 in EU with an estimated cost of €4 billion/year, rising 13% annually due to hospitalization and disease exacerbation for poor therapy adherence. Health care service providers try to increase their home-base services increasing personal visits to patients,and pneumologists try to closely follow-up patient#39;s therapy and disease evolution by telephone call. However, present solutions do not offer an integral solution able to remotely control every facet of patient#39;s management processes such as vital signs monitoring, automatic regulation of O2 flow from tanks and, telemetric therapy adherence. In WSN4LIFE, we have a 13-years valuable experience in medical device and telemedicine services and wireless sensor integration. Our innovative CRYO2 product will be offered to O2 source device sector as device and to health care service providers as telemedicine service. It will transform LTOT management, reducing distress for patients, reducing 20% hospitalization costs because of prevention in disease exacerbation and reducing by 30% the O2 consumption.Our TRL-6 prototype has been intensively tested to be readily upgraded in O2 tanks central unit. During the Phase 1 we intend to study its implementation by potentiating algorithm integration, sensors and central processing unit component miniaturization and finalizing test for remote O2 flux regulation. This will set the basis for a Phase 2 project development and launch a full commercial version by Q4 2018.We envisage CRYO2 being a great global business opportunity because no others solution offer our grade of vital sign integration and remote control. We estimate a 30k units sold and 18k service provided,a €5.4Million revenue and a ROI of 3.72 by 2023. CRYO2 will strengthen the global position of European medical device industry for oxygen therapy management and foster the home-based health care service provision for patients worldwide'

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CRYO2" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CRYO2" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More  

ClearRing (2018)

An innovative, minimally invasive medical device used for treatment of Benign Prostatic Hyperplasia symptoms.

Read More